Read the full article at PR Newswire: Clinical Trials & Medical Discoveries
General
Phase III Study Shows Novartis Drug Afinitor® More Than Doubles Time Without Tumor Growth in Advanced Pancreatic NET Patients
Read the full article at PR Newswire: Clinical Trials & Medical Discoveries
